An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
炎症特征预测一线西妥昔单抗联合铂类化疗治疗复发/转移性头颈癌的临床获益
期刊:Cells
影响因子:5.2
doi:10.3390/cells11193176
Cavalieri, Stefano; Serafini, Mara Serena; Carenzo, Andrea; Canevari, Silvana; Lenoci, Deborah; Pistore, Federico; Miceli, Rosalba; Vecchio, Stefania; Ferrari, Daris; Moro, Cecilia; Sponghini, Andrea; Caldara, Alessia; Rocca, Maria Cossu; Secondino, Simona; Moretti, Gabriella; Denaro, Nerina; Caponigro, Francesco; Vaccher, Emanuela; Rinaldi, Gaetana; Ferraù, Francesco; Bossi, Paolo; Licitra, Lisa; De Cecco, Loris
